U.S. Markets close in 31 mins.

OncoGenex Pharmaceuticals, Inc. (OGXI)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.40-0.02 (-3.85%)
As of 4:00PM EDT. Market open.
People also watch
THLDRPRXOPXAONTXCYCC
Full screen
Previous Close0.42
Open0.47
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.40 - 0.48
52 Week Range0.33 - 0.93
Volume661,692
Avg. Volume387,107
Market Cap1.09M
Beta2.96
PE Ratio (TTM)-0.61
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cubelast month

    ETFs with exposure to OncoGenex Pharmaceuticals, Inc. : July 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OncoGenex Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to OGXI-US. Comparing the performance and risk of OncoGenex Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to OncoGenex Pharmaceuticals, Inc. : April 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OncoGenex Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to OGXI-US. Comparing the performance and risk of OncoGenex Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to OncoGenex Pharmaceuticals, Inc. : April 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OncoGenex Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to OGXI-US. Comparing the performance and risk of OncoGenex Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)